Biotech RadarJobs updated

COMPANY

Veru

verupharma.com ↗

Clinical Phase 3

Keywords: oncology metastatic pancreatic cancer small molecule metabolic obesity Metastatic Breast Cancer Metastatic Castration-resistant Prostate Cancer SARS-CoV Infection Obesity & Overweight Mobility Disability HOMA-IR Muscle Loss Androgen Resistant Prostatic Cancer Advanced Prostate Adenocarcinoma Adult Respiratory Distress Syndrome Metastatic Triple Negative Breast Cancer Prostate Cancer Metastatic VERU-111 VERU-100 Veru-944

Profile checked Oct 10, 2026

12Trials (company is sponsor)

Timeline

  1. Trial start Phase 2: Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss source ↗
  2. Trial start Phase 2: Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt source ↗
  3. Trial start Phase 2: Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer source ↗
  4. Trial start Phase 3: Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer source ↗
  5. Trial start Phase 2: P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC . source ↗
  6. Trial start Phase 3: Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer source ↗
  7. Trial start Phase 3: Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent source ↗
  8. Trial start Phase 1/Phase 2: To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer source ↗
  9. Trial start Phase 3: VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study source ↗
  10. Trial start Phase 2: COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 source ↗
  11. Trial start Phase 1/Phase 2: To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer source ↗
  12. Trial start Phase 2: Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 12

RecordTitlePhaseStatusStartPrimary completion
NCT04842747VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on StudyPhase 3CompletedMay 18, 2021Jul 6, 2022 (actual)
NCT07446998Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight LossPhase 2Active, not recruitingMar 26, 20262027-10 (estimated)
NCT06282458Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight MgmtPhase 2CompletedApr 29, 2024Apr 11, 2025 (actual)
NCT05065411Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast CancerPhase 3TerminatedApr 11, 2022Oct 19, 2023 (actual)
NCT04844749Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting AgentPhase 3TerminatedJun 24, 2021May 4, 2023 (actual)
NCT04869943Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast CancerPhase 3TerminatedOct 12, 2021Jan 9, 2024 (actual)
NCT03752099To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate CancerPhase 1/Phase 2TerminatedJan 18, 2019Mar 15, 2023 (actual)
NCT04843319To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate CancerPhase 1/Phase 2TerminatedJun 9, 2021Jan 19, 2023 (actual)
NCT05079360Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast CancerPhase 2WithdrawnMar 15, 2023Mar 30, 2024 (estimated)
NCT04388826COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111Phase 2CompletedJun 18, 2020Dec 18, 2020 (actual)
NCT05008510P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC .Phase 2WithdrawnDec 30, 2021Jul 30, 2022 (estimated)
NCT03646162Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate CancerPhase 2CompletedSep 14, 2018Apr 30, 2020 (actual)
Feedback